Cleared Traditional

Annabella Breast Pump (K230672) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
147d
Days
Class 2
Risk

K230672 is an FDA 510(k) clearance for the Annabella Breast Pump. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.

Submitted by Annabella , Ltd. (Kfar Saba, IL). The FDA issued a Cleared decision on August 4, 2023 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Annabella , Ltd. devices

Submission Details

510(k) Number K230672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2023
Decision Date August 04, 2023
Days to Decision 147 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 160d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HGX Pump, Breast, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Dalia Dickman Consulting
Dalia Dickman

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HGX Pump, Breast, Powered

All 127
Devices cleared under the same product code (HGX) and FDA review panel - the closest regulatory comparables to K230672.
Electric Breast Pump
K231595 · Shenzhen Changkun Technology Co., Ltd. · Oct 2023
Willow Generation 3 Breast Pump
K230570 · Willow Innovations, Inc. · Oct 2023
Smart double sides wearable breast pump, Electric bilateral breast pump
K230102 · Huizhou Lvb Maternal and Infant Supplies Co., Ltd. · Sep 2023
Wearable Breast Pump (Model S18)
K223886 · Shenzhen TPH Technology Co., Ltd. · Jul 2023
Compact Wearable Pump
K230469 · Lansinoh Laboratories · Jun 2023
Momcozy Wearable Electric Breast Pump ( Model: S9 Pro, S12 Pro)
K230776 · Shenzhen Lutejiacheng Technology Co., Ltd. · Jun 2023